Home » Stocks » IPSC

Century Therapeutics, Inc. (IPSC)

Stock Price: $22.83 USD 2.83 (14.15%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed
After-hours: $22.70 -0.13 (-0.57%) Jun 18, 6:51 PM
Market Cap 1.20B
Revenue (ttm) n/a
Net Income (ttm) -62.25M
Shares Out 52.55M
EPS (ttm) -1.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 18
Last Price $22.83
IPO Price $20.00
Change ($) 2.83
Change (%) 14.15%
Day's Open 19.50
Day's Range 18.93 - 22.83
Day's Volume 2,500,165
52-Week Range 18.93 - 22.83

News

Century Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About IPSC

Century Therapeutics is an innovative biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. We have created a comprehensive allogeneic cell therapy platform that allows us to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, our ... [Read more...]

Industry
Biological Products
IPO Date
Jun 18, 2021
CEO
Osvaldo Flores, Ph.D.
Employees
107
Stock Exchange
NASDAQ
Ticker Symbol
IPSC
Full Company Profile

Financial Performance

Financial Statements